MedTrace Logo

Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome

NCT03232359 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2017-07-28

No results posted yet for this study

Summary

Immature platelet fraction is a non-invasive test of real time thrombopoiesis. High IPF% has been suggested as an indicator of thrombocytopenia due to rapid platelet consumption. IPF% is able to discriminate between patients with TTP/HUS or SPE/HELLP

Conditions

  • Pre-Eclampsia, Severe
  • HELLP Syndrome
  • Microangiopathy

Interventions

DIAGNOSTIC_TEST

immature platelets fraction

IPF-% and A-IPC using a reticulocyte detection channel CBC auto analyzer

Sponsors & Collaborators

  • AYMAN ABDELKADER MOHAMED ABDELKADER

    lead OTHER

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2015-12-01
Completion
2016-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03232359 on ClinicalTrials.gov